右美托咪定在腹腔镜结直肠癌手术后镇痛及恢复中应用的研究进展  

Research progress of the application of Dexmedetomidine in postoperative analgesia and recovery of laparoscopic colorectal cancer surgery

作　　者：曾爽 黎梦媛 陈春[2] ZENG Shuang;LI Meng-yuan;CHEN Chun(The First Clinical Medical College, China Three Gorges University, Hubri Province, Yichang 443003, China;Department of Anesthesiology, Yichang Central People's Hospital, Hubei Province, Yichang 443003, China)

机构地区：[1]三峡大学第一临床医学院,湖北宜昌443003 [2]湖北省宜昌市中心人民医院麻醉科,湖北宜昌443003

出　　处：《中国当代医药》2019年第16期20-23,共4页China Modern Medicine

摘　　要：结直肠癌是目前国内三大最常见的癌症类型之一,手术治疗仍然是结直肠癌最有效的治疗方式。随着腔镜器械的不断发展和手术技术的不断提高,腹腔镜微创手术因其具有创伤小、恢复快等优点,已被广泛应用于结直肠癌切除术中。但术后的疼痛及相关并发症的发生仍然影响着患者的术后康复。右美托咪定作为一种高度选择性的α2受体激动剂,已在结直肠癌手术围术期得到广泛应用并获益。本文就右美托咪定在结直肠癌手术后镇痛及术后恢复中的应用研究作一综述。Colorectal cancer is currently one of the three most common types of cancer in China, and surgical treatment is still the most effective treatment for colorectal cancer. With the continuous development of endoscopic instruments and surgical techniques, laparoscopic minimally invasive surgery has been widely used in colorectal cancer resection because of its advantages of small trauma and rapid recovery. However, postoperative pain and related complications still affect the postoperative recovery of these patients. As a highly selective α 2 agonist, Dexmedetomidine has been widely used and beneficial in the perioperative period of colorectal cancer surgery. This article reviews the application of Dexmedetomidine in postoperative analgesia and postoperative recovery of colorectal cancer.

关 键 词：右美托咪定 腹腔镜 结直肠癌切除术 术后镇痛及恢复 

分 类 号：R614[医药卫生—麻醉学]